63 related articles for article (PubMed ID: 20032382)
1. Aneuploidy is associated with TP53 expression but not with BRCA1 or TERT expression in sporadic colorectal cancer.
Schjølberg AR; Clausen OP; Burum-Auensen E; De Angelis PM
Anticancer Res; 2009 Nov; 29(11):4381-7. PubMed ID: 20032382
[TBL] [Abstract][Full Text] [Related]
2. Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer.
Gerlach U; Kayser G; Walch A; Hopt U; Schulte-Mönting J; Werner M; Lassmann S
J Pathol; 2006 Mar; 208(4):462-72. PubMed ID: 16402339
[TBL] [Abstract][Full Text] [Related]
3. Which came first? Studies clarify role of aneuploidy in cancer.
Hede K
J Natl Cancer Inst; 2005 Jan; 97(2):87-9. PubMed ID: 15657335
[No Abstract] [Full Text] [Related]
4. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
[TBL] [Abstract][Full Text] [Related]
7. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.
Reedy MB; Hang T; Gallion H; Arnold S; Smith SA
Gynecol Oncol; 2001 Jun; 81(3):441-6. PubMed ID: 11371136
[TBL] [Abstract][Full Text] [Related]
9. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer.
Pasz-Walczak G; Kordek R
Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Aberrations of BUBR1 and TP53 gene mutually associated with chromosomal instability in human colorectal cancer.
Zhao Y; Ando K; Oki E; Ikawa-Yoshida A; Ida S; Kimura Y; Saeki H; Kitao H; Morita M; Maehara Y
Anticancer Res; 2014 Oct; 34(10):5421-7. PubMed ID: 25275037
[TBL] [Abstract][Full Text] [Related]
13. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
Ko YH; Roh JH; Son YI; Chung MK; Jang JY; Byun H; Baek CH; Jeong HS
J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022
[TBL] [Abstract][Full Text] [Related]
14. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
15. Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas.
Bernard-Gallon DJ; Peffault de Latour M; Hizel C; Vissac C; Cure H; Pezet D; Dechelotte PJ; Chipponi J; Chassagne J; Bignon YJ
Anticancer Res; 2001; 21(3B):2011-20. PubMed ID: 11497291
[TBL] [Abstract][Full Text] [Related]
16. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.
Scintu M; Vitale R; Prencipe M; Gallo AP; Bonghi L; Valori VM; Maiello E; Rinaldi M; Signori E; Rabitti C; Carella M; Dallapiccola B; Altomare V; Fazio VM; Parrella P
Cancer Lett; 2007 Sep; 254(2):298-307. PubMed ID: 17498870
[TBL] [Abstract][Full Text] [Related]
18. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
20. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
